IDH.L Share News (IDH)
IDH Share
IDH Share
IDH Share
IDH Share
IDH
IDH Share
IDH Broker
IDH Directors
IDH Financial
IDH
IDH Short
IDH
Immunodiagnostic Systems (IDS), which produces manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, has unveiled what it described as a 'significant collaboration' with Diagnostica Stago, a French-based producer of coagulation and haemost
Read moreAberdeen Asset Management: Peel Hunt downgrades to hold, target price rises to 365p from 350p. Associated British Food: Investec raises target price from 1300p to 1400p, hold recommendation maintained. Barclays: JP Morgan raises target price from 250p to 320p and upgrades to overweight. Beazley:
Read moreImmunodiagnostic Systems (IDS), a producer of manual and automated specialist diagnostic testing kits, reported a decline in unaudited revenues for the five months ended August 31st. Turnover was down to £19.9m from £22.7m in the same period the previous year, partly the result of an adverse £0.5m
Read more888 Holdings: Investec upgrades from sell to buy target hiked from 18p to 95p. Advanced Medical Solutions: Singer Capital Markets upgrades to buy, target lifted from 80p to 82p. AstraZeneca: AlphaValue downgrades to reduce. Bunzl: Jefferies raises target from 835p to 860p, underperform rating kep
Read moreImmunodiagnostic Systems, a producer of manual and automated specialist diagnostic testing kits, has announced the immediate departure of its Chief Executive Officer, Ian Cookson. The company said it is now looking for a candidate who has "substantial diagnostic and international industry experien
Read moreARM Holdings: Investec maintains buy rating and 800p target. Ashtead: Jefferies ups target from 300p to 320p, buy rating retained. Bellway: Goldman Sachs downgrades to neutral. British Land: Societe Generale downgrades to sell. CRH: HSBC upgrades to overweight. Dignity: Goldman Sachs downgrades
Read moreImmunodiagnostic Systems Holdings, a firm which produces specialist dianostic testing kits, has said revenue for the year is expected to be six per cent ahead of the previous year at £53.4m (2011: £50.2m), in line with previous updates. The company expects to have generated £6.9m in cash from oper
Read moreChairman of the Audit Committee at DS Smith, Jonathan Nicholls, has bought £74,366-worth of shares in the recycled packaging firm. The purchase, which saw the non-executive buy 32,309 shares at 230.17p each, comes less than two weeks after the firm launched an agreed bid for the second largest pack
Read moreThe Chief Executive Officer of chip designer Imagination Technologies has sold off a number of shares in the firm to pay income tax and national insurance of around £3.5m, due as a result of exercising nil-cost share options under the company's employee share plan. Following the £4.6m sale of 802,
Read moreBAE Systems: Barclays Capital upgrades to overweight from neutral. Weir: JP Morgan downgrades to neutral from overweight. Royal Dutch: ING initiates coverage at buy. IMI: UBS downgrades from buy to neutral, target cut from 950p to 900p. Renishaw: UBS upgrades from neutral to buy, target hiked
Read moreDiagnostic testing kits maker Immunodiagnostic Systems has reported a £4m rise in revenue for the year to 31 August. Chairman, David Evans, said: "Revenues to 31 August are £22.6m compared with £18.4m for the comparative period in 2010. As of 31 August 299 instruments have been sold or placed an i
Read moreDiagnostic testing kits maker Immunodiagnostics Systems saw revenues and profits soar in the year to 31 March as US sales soared. The company, whose main activity is Vitamin D testing kits, saw turnover rise to £50.2m from £37.2m the previous year, while pre-tax profits rose to £16.6m from £11m. Th
Read moreImmunodiagnostic Systems said turnover for the year ending 31 March 2011 is expected to be around 35% ahead of last year's performance after strong sales of its vitamin D kits and automated products. The group, which sells its products to the US, France, Germany and Scandinavia, said trading in al
Read moreSainsbury's commercial director Michael Coupe has taken a big chunk of shares ahead of the supermarket operator's trading statement tomorrow. He took 8,621 shares at 390.53 a time, spending nearly £34,000, and now has 798,285. News of the purchase, which was made last week, comes as data from mar
Read moreImmunodiagnostic Systems (iSYS) has had a good run but Panmure Gordon observes that the stock has almost reached its target price, and so downgrades the shares. The diagnostic testing kits supplier reported strong interim results Tuesday, significantly better than the broker's forecasts with earnin
Read more
